A unique asset we have within our delivery offering is our Research & Strategy (R&S) team, made up of science postgraduates, medical doctors, expert marketers, and experienced life science researchers. Their decades of collective experience enable them to provide data-driven solutions for clients across all areas of the sector. They excel in bringing life to the insights they gather, not just interpreting data but being able to offer actionable propositions that align with client commercial goals.
A recent initiative brought together by the R&S team is a market insights series consisting of quarterly whitepapers. They aim to utilize valuable ramarketing-owned data collated from hundreds of interviews and research projects, summarizing key learnings and trends from the life science sector.
This never-before-shared data takes insights from C-suite professionals and research experts, enabling us to see our industry through a different lens.
Our first whitepaper, ‘The biotech blueprint for ranking and selecting vendors‘, delves into how biotech companies choose outsourcing partners and the key criteria they consider. It offers a proprietary analysis based on in-depth qualitative interviews conducted by our R&S team. Co-authored by Joao Incio and Katie Kovalevich, sector leads in the Bio and CDMO sectors respectively, this whitepaper is a valuable resource for biotech decision-makers.
In our latest whitepaper, ‘Harnessing the power of customer analytics‘, we offer a comprehensive exploration of decision-making drivers based on case studies conducted by our R&S team. This whitepaper covers various topics, including the benefits of using customer data to drive marketing strategy, key decision-makers, conference and event drivers, and the impact on investor involvement. It is a must-read for anyone looking to leverage customer analytics to maximize marketing efforts.
It’s time to have your say…
The primary goal for the market insights project is to create content that speaks to your pain points, as well as your current and future company goals. Our experts can then craft content that speaks to your most pressing matters, providing clarity and the insights you need to make informed decisions about your future strategy.
Please take a few minutes to fill out this short anonymous survey to let us know what other topics you would like the team to explore!
Joao joins us having worked in the biomedical sector for over 15 years in the US, UK, and EU. He is a former medical doctor and a Harvard-trained scientist, with a Ph.D. in Molecular Medicine and Oncology. Joao’s role in our Research & Strategy department is to be the ‘go-to-guru’ for our teams throughout any project; he uses his industry insight and past experience to inform research projects and content delivery.
Laura brings first-hand global life science knowledge to the agency to ensure our finger is on the pulse of all the exciting things happening in the industry. Before ramarketing, Laura built an impressive career as Program Director in some of the largest multinational CROs, delivering high-value and high-complexity global trials, from Ph 1 through Ph 3.
Gillian leads the coordination of research projects for clients, providing brand strategy recommendations based on data and insights. She has 10 years of experience delivering global, integrated marketing campaigns for Fortune 500 clients; during her time in the life science sector, she has worked with a range of clients specializing in pharmaceutical packaging, analytical instrumentation, and data technology for clinical trials.
Katie’s vast experience across multiple CDMOs is invaluable to the ramarketing team; her time working for life science giants such as Alcami, Catalent, and Cambrex gave her insight into client and customer behavior that still informs her work today. Her focus is to ensure that our Account Management and Business Development teams are up-to-date on the industries they are serving and that our CDMO clients have the assurance that our experts have walked in their shoes.
Catherine is a CIM Chartered Marketer and science postgraduate who dovetails in-depth scientific understanding with creativity to deliver world-class strategies underpinned by deep market, customer, and competitor insights. Following a decade in R&D spanning infectious disease, autoimmune disease, oncology, and neuromuscular disorders, Catherine transitioned from the lab to scientific sales and business development, and then marketing.
Related news, insight and opinion